Ironwood Pharmaceuticals Inc (IRWD)
Sutro Biopharma Inc (STRO)
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Abivax (ABVX)
Abivax Provides 2026 Corporate Outlook
Intellia Therapeutics Inc (NTLA)
Solid Biosciences Inc (SLDB)
Definitive Healthcare Corp (DH)
Definitive Healthcare Corp (DH)
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference
Phathom Pharmaceuticals Inc (PHAT)
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Annexon Inc (ANNX)
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Krystal Biotech (KRYS)
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis
Arcus Biosciences Inc. (RCUS)
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference
RAPT Therapeutics Inc (RAPT)
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference